Beryllium Claims

EEOICPA, beryllium,  lung, pulmonary

Video 1 title

This is an example of a Vimeo video, just edit the change the video link, edit the title and this description and if you like, you can also link the continue button to a web page....

Video 2 title

This is an example of a Vimeo video, just edit the change the video link, edit the title and this description and if you like, you can also link the continue button to a web page....

Video 3 title

This is an example of a Vimeo video, just edit the change the video link, edit the title and this description and if you like, you can also link the continue button to a web page....

Video 4 title

This is an example of a Vimeo video, just edit the change the video link, edit the title and this description and if you like, you can also link the continue button to a web page....

 Manhattan Project Badge

Help for EEOICPA claimants

 
Bookmark and Share
follow EECAP on facebook tweet EECAP EECAP YouTube Channel
get in touch

 Beryllium Claims

 

Historic DOE Safety PosterBeryllium Disease and EEOICPA

Workers from facilities covered by EEOICPA who suffer from beryllium diseases may be eligible for compensation under the EEOICPA under Part B and Part E.  Under Part B workers with Chronic Beryllium Disease (CBD) or beryllium sensitivity are covered. Under Part E workers may be covered for illnesses caused by beryllium as a toxic substance.  Employees of beryllium vendors are not eligible for benefits under Part E of the EEOICPA. However, uranium miners, millers, and ore transporters as defined under Section 5 of the Radiation Exposure Compensation Act (RECA) may be eligible for Part E benefits.

There are separate requirements that must be met depending on when the worker first was diagnosed with Chronic Beryllium Disease.

1. If CBD was diagnosed before January 1, 1993, the medical documentation must include exposure to beryllium, plus three of the five following criteria:

  • Immunologic tests showing beryllium sensitivity (skin patch test or beryllium blood test
  • Characteristic chest X-ray or computed tomography (CT) abnormalities
  • Restrictive or obstructive lung physiology testing or diffusing lung capacity defect
  • Lung pathology consistent with CBD
  • Clinical course consistent with a chronic respiratory disorder

2.  If CBD was diagnosed on or after January 1, 1993, the medical documentation must include: an abnormal beryllium lymphocyte proliferation test (BeLPT), or an abnormal beryllium lymphocyte transformation test (BeLTT), performed on either blood or lung lavage cells; lung pathology consistent with CBD; plus any of the following:

  • A lung biopsy showing granulomas or a lymphocytic process consistent with CBD
  • A Computerized Axial Tomography (CAT) scan showing changes consistent with CBD
  • A pulmonary function study or exercise tolerance test showing pulmonary deficits consistent with CBD

  •  

    Useful Documents on Beryllium Disease
  •  Communicating Health Risks Working Safely with Beryllium: Training Reference for Beryllium
    Workers and Managers/Supervisors, Beryllium Health Risk Communication Task Force, April 2002
  • The Psychosocial Effects of Beryllium Sensitization and Chronic Beryllium Disease - Miller, 2012
  • The Psychosocial Effects of Beryllium Sensitization and Chronic Beryllium Disease PowerPoint Slides - Miller, 2013
  •  

     

    back to top

     Photos courtesy of DOE and Library of Congress